Genomic Health, Inc. · Redwood City, CA United States (NASDAQ: GHDX)
Key Genomic Health, Inc. Financials
| Company Type | Public -(NASDAQ: GHDX) Single Location |
|---|---|
| Fiscal Year-End | December |
| 2003 Sales (mil.) | $0.1 |
| 2010 Employees | 472 |
Genomic Health, Inc. Income Statement
| Dec 03 | Dec 02 | Dec 01 | |
| Revenue | 0.1 | 0.0 | 0.0 |
| Cost of Goods Sold | 0.0 | 0.0 | 0.0 |
| Gross Profit | 0.1 | 0.0 | 0.0 |
| Gross Profit Margin | 100% | -- | -- |
| SG&A Expense | -- | -- | 3.0 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | (15.4) | (11.6) | (14.0) |
| Operating Margin | -12348% | --% | --% |
| Nonoperating Income | -- | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (15.3) | (11.1) | (12.8) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (15.3) | (11.1) | (12.8) |
| Total Net Income | (15.3) | (11.1) | (12.8) |
| Net Profit Margin | -12200% | --% | --% |
| Diluted EPS from Total Net Income | (12.43) | (11.95) | (20.14) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Genomic Health, Inc. Balance Sheet
| Assets | Dec 03 | Dec 02 | Dec 01 |
| Current Assets | |||
| Cash | -- | 25.3 | 28.7 |
| Net Receivables | -- | -- | -- |
| Inventories | -- | -- | -- |
| Other Current Assets | -- | -- | -- |
| Total Current Assets | -- | -- | -- |
| Net Fixed Assets | -- | -- | -- |
| Other Noncurrent Assets | 13.1 | 27.4 | 30.4 |
| Total Assets | 13.1 | 27.4 | 30.4 |
| Liabilities | Dec 03 | Dec 02 | Dec 01 |
| Current Liabilities | |||
| Accounts Payable | -- | -- | -- |
| Short-Term Debt | -- | 0.2 | 0.0 |
| Other Current Liabilities | -- | -- | -- |
| Total Current Liabilities | -- | -- | -- |
| Long-Term Debt | -- | -- | 0.0 |
| Other Noncurrent Liabilities | 52.6 | 0.8 | 2.1 |
| Total Liabilities | 52.6 | 0.8 | 2.1 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 51.1 | 51.1 | 41.8 |
| Common Stock Equity | (90.6) | (24.5) | (13.5) |
| Total Equity | (39.5) | 26.6 | 28.3 |
| Shares Outstanding (thou.) | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Genomic Health, Inc. Cash Flow Statement
| Dec 03 | Dec 02 | Dec 01 | |
| Net Operating Cash Flow | -- | -- | -- |
| Net Investing Cash Flow | -- | -- | -- |
| Net Financing Cash Flow | |||
| Net Change in Cash | |||
| Depreciation & Amortization | |||
| Capital Expenditures | |||
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.